News
GSK RSV vaccine Arexvy accepted for regulatory review by EMA to expand use in adults 18 years, older
London: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to ...
India also impacted by Shigellosis, a severe form of bacterial diarrhoea that disproportionately affects children under five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results